Lyngby, Denmark

Erwing Ludo Roggen

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Novozymes A/s. Active years: 2010-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Erwing Ludo Roggen. Retrieved from https://idiyas.com/inventor/erwing-ludo-roggen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010-2013

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Erwing Ludo Roggen: Innovator in Subtilase Technology

Introduction

Erwing Ludo Roggen is a notable inventor based in Lyngby, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of subtilase variants. With a total of 2 patents, his work focuses on enhancing the immunogenicity of these enzymes.

Latest Patents

Roggen's latest patents include innovations related to subtilase subtilases with altered immunogenicity. These inventions specifically address the need for subtilases with reduced allergenicity. The patents also cover the expression of these subtilase variants and their applications in various products, such as detergents and oral care items.

Career Highlights

Erwing Ludo Roggen is associated with Novozymes A/S, a leading company in the biotechnology sector. His work at Novozymes has allowed him to explore and develop new enzymatic solutions that have practical applications in everyday products.

Collaborations

Throughout his career, Roggen has collaborated with esteemed colleagues, including Stefan Minning and Henriette Draborg. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Erwing Ludo Roggen's innovative work in subtilase technology showcases his commitment to improving enzyme applications in various industries. His contributions continue to impact the field of biotechnology positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…